Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has submitted the schedule of analyst/institutional investors meeting that the Company would be participating on 8 March 2022.
The above information is a part of company’s filings submitted to BSE.